KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Current Deferred Revenue (2016 - 2026)

Medpace Holdings filings provide 12 years of Current Deferred Revenue readings, the most recent being $856.3 million for Q1 2026.

  • On a quarterly basis, Current Deferred Revenue rose 19.15% to $856.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $856.3 million, a 19.15% increase, with the full-year FY2025 number at $854.4 million, up 20.24% from a year prior.
  • Current Deferred Revenue hit $856.3 million in Q1 2026 for Medpace Holdings, roughly flat from $854.4 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $856.3 million in Q1 2026 to a low of $367.2 million in Q1 2022.
  • Median Current Deferred Revenue over the past 5 years was $616.7 million (2024), compared with a mean of $611.4 million.
  • Biggest five-year swings in Current Deferred Revenue: surged 42.22% in 2022 and later increased 16.54% in 2025.
  • Medpace Holdings' Current Deferred Revenue stood at $462.7 million in 2022, then increased by 20.99% to $559.9 million in 2023, then increased by 26.92% to $710.6 million in 2024, then rose by 20.24% to $854.4 million in 2025, then rose by 0.23% to $856.3 million in 2026.
  • The last three reported values for Current Deferred Revenue were $856.3 million (Q1 2026), $854.4 million (Q4 2025), and $834.3 million (Q3 2025) per Business Quant data.